Richard Lewkowicz
Internal Medicine · New York, NYNPI 1134319015
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $5,040 and has fallen 94.1% since, to $298 in 2025. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $109.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- AbbVie$789
- Lundbeck LLC$625
- MDD US Operations, LLC$533
- Avanir Pharmaceuticals, Inc.$517
- Otsuka America Pharmaceutical, Inc.$506
- plus $5K from 28 others
What the payments were for
- Food & beverage$8,950100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 10 | $1,211 |
| AbbVie(2 entities) | 7 | $789 |
| Lundbeck LLC | 5 | $625 |
| MDD US Operations, LLC | 4 | $533 |
| Avanir Pharmaceuticals, Inc. | 7 | $517 |
| Otsuka America Pharmaceutical, Inc. | 4 | $506 |
| Novo Nordisk | 4 | $492 |
| Acorda Therapeutics, Inc | 3 | $379 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $375 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $368 |
| Teva Pharmaceuticals USA, Inc. | 3 | $363 |
| Abbott | 2 | $245 |
| Lilly USA, LLC | 6 | $193 |
| Astellas Pharma US Inc | 2 | $169 |
| Bayer | 1 | $155 |
| Mallinckrodt Hospital Products Inc. | 1 | $141 |
| Ironshore Pharmaceuticals Inc. | 2 | $127 |
| Alkermes, Inc. | 1 | $125 |
| Viiv Healthcare Company | 1 | $125 |
| Boehringer Ingelheim | 1 | $125 |
| Harmony Biosciences LLC | 1 | $125 |
| Amgen | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Nestle Healthcare Nutrition Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Eisai Inc. | 1 | $120 |
| Pfizer | 1 | $119 |
| Radius Health, Inc. | 1 | $118 |
| AstraZeneca | 1 | $117 |
| Kyowa Kirin, Inc. | 1 | $92 |
| Corcept Therapeutics | 1 | $76 |
| Johnson & Johnson | 1 | $64 |
| Intra-sana Laboratories | 1 | $50 |
| Exact Sciences | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,967 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.